EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia
This study is ongoing, but not recruiting participants.
Sponsor:
Massachusetts General Hospital
Collaborator:
Information provided by (Responsible Party):
Emery Brown, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01543633
First received: February 16, 2012
Last updated: March 2, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to investigate how the commonly used anesthetic drug propofol works in the brain to produce loss of consciousness. While under general anesthesia your brain waves will be measured using electroencephalogram (EEG). On a separate day, the patient's brain will be imaged using magnetic resonance imaging (MRI).
| Condition | Intervention |
|---|---|
|
Brain Activity Under Sedation |
Drug: Propofol |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Electroencephalogram Studies of Induction and Recovery From Propofol Induced General Anesthesia |
Resource links provided by NLM:
Further study details as provided by Massachusetts General Hospital:
Primary Outcome Measures:
- Localize and track brain activity under propofol sedation. [ Time Frame: 11 hours ] [ Designated as safety issue: No ]The primary goal of this trial is to localize and track changes in brain activity during loss and recovery of consciousness induced by propofol using source localization from EEG recordings analyzed with spectral methods, source localizations techniques and event-related potentials.
| Estimated Enrollment: | 80 |
| Study Start Date: | August 2005 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Active Study Arm
Subjects recruited into this study will be required to undergo a base MRI scan of the brain. On a separate day propofol will be administered with concurrent EEG while subjects respond to stimuli.
|
Drug: Propofol
Propofol will be infused using a computer controlled delivery system running the program STANPUMP. Loss of consciousness will be defined as loss of response to auditory stimulus (button press).
|
Eligibility| Ages Eligible for Study: | 18 Years to 36 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Healthy, non-smoking male and female volunteers, ages 18-36 with normal body weight.
- American Society of Anesthesiologists (ASA) physical status I
Exclusion Criteria:
- History of head trauma
- Surgical aneurysm clips
- Cardiac pacemaker
- Prosthetic heart valve
- Neurostimulator
- Implanted pumps
- Cochlear implants
- Metal rods, plates
- Screws
- Intrauterine device
- Hearing aid
- Dentures (which might create NMR artifacts)
- Metal injury to eyes
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01543633
Locations
| United States, Massachusetts | |
| Massachusetts General Hospital | |
| Boston, Massachusetts, United States, 02114 | |
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
| Principal Investigator: | Emery N Brown, M.D., Ph.D. | Massachusetts General Hospital |
More Information
No publications provided
| Responsible Party: | Emery Brown, Emery N. Brown, M.D., Ph.D., Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT01543633 History of Changes |
| Other Study ID Numbers: | 2005P001549, 5DP1OD003646 |
| Study First Received: | February 16, 2012 |
| Last Updated: | March 2, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Additional relevant MeSH terms:
|
Anesthetics Propofol Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Anesthetics, Intravenous Anesthetics, General Hypnotics and Sedatives |
ClinicalTrials.gov processed this record on May 23, 2013